Vor Biopharma Inc (VOR)

NASDAQ
12.52
-1.10(-8.08%)
After Hours
13.81
+1.29(+10.30%)
- Real-time Data
  • Volume:
    53,268
  • Bid/Ask:
    11.84/13.87
  • Day's Range:
    12.42 - 13.54

VOR Overview

Prev. Close
13.62
Day's Range
12.42-13.54
Revenue
-
Open
13.15
52 wk Range
12.03-63.62
EPS
-
Volume
53,268
Market Cap
464.89M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
138,629
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
37,131,633
Next Earnings Date
Dec 01, 2021
What is your sentiment on Vor Biopharma Inc?
or
Market is currently closed. Voting is open during market hours.

Vor Biopharma Inc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellSell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellNeutral
SummaryStrong SellStrong SellStrong SellStrong SellNeutral

Vor Biopharma Inc Company Profile

Vor Biopharma Inc Company Profile

Employees
92

Vor Biopharma, Inc., early-stage cell therapy company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in preclinical development to treat acute myeloid leukemia (AML) and other hematological malignancies. The company’s VOR33 eHSCs lacks CD33, a protein that is expressed by AML cancer cells. Vor Biopharma, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Read More
  • this hasn't updated 😔
    0
    • In line for the ride 🚀🚀
      0
      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.